This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Re, R. Search for Related Content PubMed PubMed Citation Articles by Re, R. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Hormones Related Collections ACE/Angiotension receptors Cell biology/structural biology

(Hypertension. 1999;34:534-538.)
© 1999 American Heart Association, Inc.

Hypothesis

The Nature of Intracrine Peptide Hormone Action

Richard Re

From the Division of Research, Alton Ochsner Medical Foundation, New Orleans, La.

Abstract—Current theory holds that peptide hormone action results from hormone binding to cell-surface receptors, with the generation of intracellular second messengers. However, a growing body of evidence suggests that intracellular peptide hormone, either internalized or synthesized in situ, can exert physiologically relevant effects. These effects are diverse and poorly understood. I propose that such intracrine action can serve to modulate cellular function over time and thereby play a role in biological memory of various sorts, in the maintenance of hormonal responsiveness, and in cellular differentiation.

Key Words: intracrine • peptides • nucleus • memory • differentiation

This article has been cited by other articles:

				R. N. Re and J. L. Cook Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H893 - H901. [Abstract] [Full Text] [PDF]

				R. N. Re and J. L. Cook The physiological basis of intracrine stem cell regulation Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H447 - H453. [Abstract] [Full Text] [PDF]

				R. N. Re and J. L. Cook The Basis of an Intracrine Pharmacology J. Clin. Pharmacol., March 1, 2008; 48(3): 344 - 350. [Abstract] [Full Text] [PDF]

				F. Gobeil Jr., T. Zhu, S. Brault, A. Geha, A. Vazquez-Tello, A. Fortier, D. Barbaz, D. Checchin, X. Hou, M. Nader, et al. Nitric Oxide Signaling via Nuclearized Endothelial Nitric-oxide Synthase Modulates Expression of the Immediate Early Genes iNOS and mPGES-1 J. Biol. Chem., June 9, 2006; 281(23): 16058 - 16067. [Abstract] [Full Text] [PDF]

				H. Haller, J.-K. Park, C. Lindschau, M. Meyer, and J. Menne Intrarenal renin-angiotensin system -- important player of the local milieu Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2): 122 - 125. [PDF]

				E. D. Frohlich Left ventricular hypertrophy: a "factor of risk": Mass is reversible, but is the risk? J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2216 - 2218. [Full Text] [PDF]

				A. Stanton, C. Jensen, J. Nussberger, and E. O'Brien Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren Hypertension, December 1, 2003; 42(6): 1137 - 1143. [Abstract] [Full Text] [PDF]

				F. Gobeil Jr., S. G. Bernier, A. Vazquez-Tello, S. Brault, M. H. Beauchamp, C. Quiniou, A. M. Marrache, D. Checchin, F. Sennlaub, X. Hou, et al. Modulation of Pro-inflammatory Gene Expression by Nuclear Lysophosphatidic Acid Receptor Type-1 J. Biol. Chem., October 3, 2003; 278(40): 38875 - 38883. [Abstract] [Full Text] [PDF]

				B. Hu, S. Wang, Y. Zhang, C. A. Feghali, J. R. Dingman, and T. M. Wright A nuclear target for interleukin-1{alpha}: Interaction with the growth suppressor necdin modulates proliferation and collagen expression PNAS, August 19, 2003; 100(17): 10008 - 10013. [Abstract] [Full Text] [PDF]

				R. N. Re Intracellular Renin and the Nature of Intracrine Enzymes Hypertension, August 1, 2003; 42(2): 117 - 122. [Abstract] [Full Text] [PDF]

				A. Stanton Review: Potential of renin inhibition in cardiovascular disease Journal of Renin-Angiotensin-Aldosterone System, March 1, 2003; 4(1): 6 - 10. [Abstract] [PDF]

				R. N. Re Implications of intracrine hormone action for physiology and medicine Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H751 - H757. [Full Text] [PDF]

				L. G. Navar, L. M. Harrison-Bernard, A. Nishiyama, and H. Kobori Regulation of Intrarenal Angiotensin II in Hypertension Hypertension, February 1, 2002; 39(2): 316 - 322. [Abstract] [Full Text] [PDF]

				J. L. Zhuo, J. D. Imig, T. G. Hammond, S. Orengo, E. Benes, and L. G. Navar Ang II Accumulation in Rat Renal Endosomes During Ang II-Induced Hypertension: Role of AT1 Receptor Hypertension, January 1, 2002; 39(1): 116 - 121. [Abstract] [Full Text] [PDF]

				R. N. Re On Not Being the Last to Give Up the Old or the First to Adopt the New Hypertension, October 1, 2001; 38(4): 759 - 760. [Full Text] [PDF]

				R. N. Re On the Biological Actions of Intracellular Angiotensin Hypertension, June 1, 2000; 35(6): 1189 - 1190. [Full Text] [PDF]

				J. L. Cook, Z. Zhang, and R. N. Re In Vitro Evidence for an Intracellular Site of Angiotensin Action Circ. Res., December 7, 2001; 89(12): 1138 - 1146. [Abstract] [Full Text] [PDF]